Trial Profile
Phase 1/2a study of MYO-102.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 20 Dec 2017
Price :
$35
*
At a glance
- Drugs Patidistrogene bexoparvovec (Primary)
- Indications Sarcoglycanopathies
- Focus Adverse reactions; Therapeutic Use
- 20 Dec 2017 New trial record